ISSN 2097-6054(网络) ISSN 1672-9234(印刷) CN 11-5289/R
主管:中国科学技术协会 主办:中华护理学会
出版:中华护理杂志社
收录:中国科学引文数据库(CSCD)来源期刊
   中国期刊全文数据库
   中国核心期刊(遴选)数据库
   Scopus
临床实践

甲状腺癌患者行 131I治疗后体外辐射剂量变化研究

  • 陈伟娜 ,
  • 韩星敏 ,
  • 周纪妹 ,
  • 贺旖君
展开
  • 450000 郑州市 郑州大学第一附属医院
陈伟娜:女,本科,主管护师,E-mail: 2873147431@qq.com

收稿日期: 2018-09-04

  网络出版日期: 2019-08-08

Radiation dose changes of thyroid cancer patients after 131I treatment

  • Wei-na CHEN ,
  • Xing-min HAN ,
  • Ji-mei ZHOU ,
  • Yi-jun HE
Expand

Received date: 2018-09-04

  Online published: 2019-08-08

摘要

目的 了解分化型甲状腺癌术后行 131I治疗的患者体外辐射剂量变化,探讨患者出院日及临床过程中的辐射防护方法。 方法 选取分化型甲状腺癌术后进行 131I治疗的患者74例,在治疗后24 h、48 h、72 h、96 h,使用放射性核素治疗监护机器人测量距患者颈部及1 m处的体外辐射剂量水平,并与出院参考标准进行比较。 结果131I治疗后24 h、48 h、72 h、96 h,距患者1 m处辐射剂量为270.11(202.46,427.18)、64.02(39.01,101.19)、16.74(10.07,27.69)、5.28(3.41,10.40);行 131I治疗后24 h、48 h、72 h、96 h,辐射剂量符合出院要求的患者分别为0例、2例(2.7%)、52例(70.3%)、70例(94.6%)。 结论 甲状腺癌患者行 131I治疗后体外辐射剂量变化差异性较大,建议动态检测患者行 131I治疗后1 m处的体外辐射剂量,按照辐射剂量要求执行个体化出院时间。医护人员接触患者时要做好防护,可使用放射性核素治疗监护机器人完成部分工作。

本文引用格式

陈伟娜 , 韩星敏 , 周纪妹 , 贺旖君 . 甲状腺癌患者行 131I治疗后体外辐射剂量变化研究[J]. 中华护理教育, 2019 , 16(7) : 541 -543 . DOI: 10.3761/j.issn.1672-9234.2019.07.016

Abstract

Objective To understand the radiation dose changes of patients receiving iodine after operation for differentiated thyroid cancer,and to discuss the best protection when patients were discharged and during the process of staying in hospital.Methods A total of 74 patients with differentiated thyroid cancer who received 131I treatment after surgery were selected. At 24 h,48 h,72 h and 96 h after treatment,the radiation dose levels on the neck and 1m far away from the patients were measured by the radionuclide therapy monitoring robot,and compared with the reference standards of discharge. Results At 24 h,48 h,72 h and 96 h after 131I treatment,the radiation dose 1m away from the patient was 270.11(202.46,427.18),64.02(39.01,101.19),16.74(10.07,27.69),5.28(3.41,10.40)respectively. At 24 h,48 h,72 h and 96 h after 131I treatment,0 patient,2 patients(2.7%),52 patients(70.3%)and 70 patients(94.6%)met the discharge dose requirements. Conclusion Radiation dose changes of thyroid cancer patients after 131I treatment is great among different patients. It is suggested to dynamically detect the radiation dose at 1 m after 131I treatment and individualized discharge schedule is advocated. Medical staff should be well protected when contacting patients,and the radionuclide therapy monitoring robot can be used to complete part of the work.

参考文献

[1] 杨明 . 131Ⅰ治疗甲亢的辐射风险与防护[J]. 中国保健营养(中旬刊) , 2013(9):25-26.
[2] 宋百锋 . 131I治疗甲亢的辐射风险与防护研究 [D]. 苏州:苏州大学, 2010.
[3] 中华医学会核医学分会. 分化型甲状腺癌术后 131I治疗临床路径专家共识(2017版) [J]. 中华核医学与分子影像杂志, 2018,38(6):416-419.
[4] 汤敏敏 . 分化型甲癌患者 131I治疗后体内残留放射性活度的评估 [D]. 太原:山西医科大学, 2013.
[5] 任庆余, 王琳杰, 赵进沛 . 碘-131治疗分化型甲状腺癌外照射辐射剂量研究[J]. 中国职业医学, 2017,44(5):625-628.
[6] 易于颦, 朱玉泉, 段东 , 等. 分化型甲状腺癌患者 131I治疗后大量饮水开始时间的研究 [J]. 中华护理杂志, 2018,53(1):8-11.
[7] Khan SA, Khan MS, Arif M , et al. Radiation dose-rate reduction pattern in well-differentiated thyroid cancer treated with I-131[J]. J Coll Physicians Surg Pak, 2015,25(7):510-513.
[8] 靳平燕 . 131I治疗分化型甲状腺癌患者辐射剂量率研究 [D]. 广州:南方医科大学, 2016.
[9] Sisson JC, Freitas J , McDougall IR,et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I:practice recommendations of the American Thyroid Association [J]. Thyroid, 2011,21(4):335-346.
[10] 郑钧正 . 《电离辐射防护与辐射源安全基本标准》关于职业照射的控制[J]. 中国职业医学, 2006,33(4):299-303.
文章导航

/